Latisse Faces Patent Challenge
The FDA said a company is challenging Allergan’s patent protection for the eyelash drug Latisse, looking to make a generic version. (Source: WSJ.com: Health)
See original here:
Latisse Faces Patent Challenge
Long Lashes Without Prescription, but With Risks
A glaucoma eyedrop, reinvented, is routinely available without a doctor’s prescription or visit. (Source: NYT Health)
More here:
Long Lashes Without Prescription, but With Risks
Latisse lash lengthener has its fans and detractors
Many users swear by its effectiveness, but the drug, developed to treat glaucoma, can have unpleasant side effects. Taking a prescription drug for a cosmetic side effect — at the risk of other side effects — may seem risky
See the original post:
Latisse lash lengthener has its fans and detractors
FDA: Eyelash Thickener Claims Misleading
Web Site for Latisse Avoids or Downplays Side Effects Associated with Product (Source: Health News: CBSNews.com)
Continue reading here:
FDA: Eyelash Thickener Claims Misleading
FDA: Allergan’s Web Site Is Misleading
The FDA said the Web site of Allergan’s Latisse is misleading because it suggests the company’s eyelash thickener is more safe than proven. (Source: WSJ.com: Health)
Read more:
FDA: Allergan’s Web Site Is Misleading
Chance side effect creates thick eyelashes, market for Latisse
Another drug is getting a second life because of desirable side effects. (Source: USATODAY.com Health)
View original post here:
Chance side effect creates thick eyelashes, market for Latisse
FDA Approves Allergan’s Drug for Longer Eyelashes
Allergan Inc, maker of Botox, said on Friday that the U.S. Food and Drug Administration has approved its eyelash-thickening drug Latisse.
Excerpt from:
FDA Approves Allergan’s Drug for Longer Eyelashes
FDA OKs 1st Eyelash Drug Latisse
Title: FDA OKs 1st Eyelash Drug LatisseCategory: Health NewsCreated: 12/29/2008Last Editorial Review: 12/29/2008 (Source: MedicineNet Eyesight General) MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network , and receive $5 free advertising.
Go here to see the original:
FDA OKs 1st Eyelash Drug Latisse
Allergan Eyelash Enhancer Approved
Allergan received FDA approval to market Latisse, a beauty treatment that increases the length, thickness and darkness of eyelashes by using a drug the company developed to treat glaucoma. (Source: WSJ.com: Health)
Original post:
Allergan Eyelash Enhancer Approved
Epione Beverly Hills- Revolutionary New Sunblock Formula ‘Protects and Corrects’
- Epione Beverly Hills Helps Kick Off 2010 Teen Choice Awards’ Festivities with KIIS FM
- Beverly Hills Leader in Cosmetic Procedures Earns Allergan’s Highest Level of Recognition
- Dr. Simon Ourian to Offer Industry Expertise to Medicis
- The Cast of ‘Jersey Shore’ Learns Safe Tanning Tips and Secrets from Epione Beverly Hills
- Image is Everything: Three Aesthetic Treatments for Building Confidence and Looking and Feeling Your Best
- Why More Women are Choosing OptiLipo over Liposuction
- Say “Adios” to Acne Scars
- New Laser Treatment Offers Revolutionary Response to Aesthetic Procedure Candidates’ Number One Concern: Recovery Time
- Epione Reveals a “Bright” New Solution for Dull, Sun Damaged Skin